Your browser doesn't support javascript.
loading
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma.
Dorado García, Heathcliff; Pusch, Fabian; Bei, Yi; von Stebut, Jennifer; Ibáñez, Glorymar; Guillan, Kristina; Imami, Koshi; Gürgen, Dennis; Rolff, Jana; Helmsauer, Konstantin; Meyer-Liesener, Stephanie; Timme, Natalie; Bardinet, Victor; Chamorro González, Rocío; MacArthur, Ian C; Chen, Celine Y; Schulz, Joachim; Wengner, Antje M; Furth, Christian; Lala, Birgit; Eggert, Angelika; Seifert, Georg; Hundsoerfer, Patrick; Kirchner, Marieluise; Mertins, Philipp; Selbach, Matthias; Lissat, Andrej; Dubois, Frank; Horst, David; Schulte, Johannes H; Spuler, Simone; You, Daoqi; Dela Cruz, Filemon; Kung, Andrew L; Haase, Kerstin; DiVirgilio, Michela; Scheer, Monika; Ortiz, Michael V; Henssen, Anton G.
Afiliación
  • Dorado García H; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Pusch F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Bei Y; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • von Stebut J; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Ibáñez G; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Guillan K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Imami K; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Gürgen D; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Rolff J; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Helmsauer K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Meyer-Liesener S; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Timme N; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Bardinet V; Experimental Pharmacology and Oncology (EPO), Berlin, Germany.
  • Chamorro González R; Experimental Pharmacology and Oncology (EPO), Berlin, Germany.
  • MacArthur IC; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Chen CY; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schulz J; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Wengner AM; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Furth C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Charité Campus Buch, Lindenberger Weg 80, 13125, Berlin, Germany.
  • Lala B; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Eggert A; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Seifert G; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hundsoerfer P; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Kirchner M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Mertins P; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Selbach M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Lissat A; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, Berlin, Germany.
  • Dubois F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Horst D; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Schulte JH; Bayer AG, Berlin, Germany.
  • Spuler S; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • You D; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Dela Cruz F; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kung AL; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Haase K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • DiVirgilio M; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Scheer M; Berlin Institute of Health, 10178, Berlin, Germany.
  • Ortiz MV; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Henssen AG; Berlin Institute of Health, 10178, Berlin, Germany.
Nat Commun ; 13(1): 4297, 2022 07 25.
Article en En | MEDLINE | ID: mdl-35879366
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Rabdomiosarcoma Embrionario / Rabdomiosarcoma Alveolar Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Rabdomiosarcoma Embrionario / Rabdomiosarcoma Alveolar Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania